OBJECTIVE
To improve results for locally advanced prostate cancer, a prospective clinical trial of concurrent external beam irradiation and fractionated iridium-192 (Ir-192) high dose rate (HDR) conformal boost brachytherapy was initiated.
METHODS
Between November 1991 and February 1994, 99 implants